I thought i would note down the following all in Australian Dollars .
1.Acadia paid approx $14 million for shares in Neuren
2. Potential milestone payments for trofinetide in north america for retts and fragile x .$660 mill.
3.Potential royalties for trofinetde in north america $800 mill(est).
4.Acadia potentially spending $200 mill on trofinetide trials .
5.Potential row deal assuming 30% of north america market say $625 mill
6.NNZ2591 worth say $100 mill.
7.Total $2399 mill.
Based on the about you would think that the current share price is cheap.
Current Price of $2.30 versus potential .
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.92 |
Change
-0.750(3.81%) |
Mkt cap ! $2.416B | |||
| Open | High | Low | Value | Volume |
| $19.28 | $19.42 | $18.62 | $8.503M | 448.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 275 | $18.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.08 | 2240 | 3 |
View Market Depth
| Last trade - 16.10pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$18.95 |
Change
-0.750 ( 3.08 %) |
||||
| Open | High | Low | Volume | ||
| $19.32 | $19.32 | $18.62 | 97808 | ||
| Last updated 15.59pm 19/04/2024 ? | |||||
| NEU (ASX) Chart |